Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1esv | LAR | Actin, alpha skeletal muscle |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 1esv | LAR | Actin, alpha skeletal muscle | / | 1.000 | |
| 4b1u | LAB | Actin, alpha skeletal muscle | / | 0.552 | |
| 1rdw | LAR | Actin, alpha skeletal muscle | / | 0.534 | |
| 3buz | LAR | Actin, alpha skeletal muscle | / | 0.524 | |
| 1sqk | LAR | Actin, alpha skeletal muscle | / | 0.518 | |
| 4pkh | ADP | Actin, alpha skeletal muscle | / | 0.514 | |
| 1c0f | ATP | Major actin | / | 0.497 | |
| 4k42 | ADP | Actin, alpha skeletal muscle | / | 0.497 | |
| 2q0u | LAB | Actin, alpha skeletal muscle | / | 0.496 | |
| 3sjh | LAR | Actin, alpha skeletal muscle | / | 0.474 | |
| 4h03 | LAR | Actin, alpha skeletal muscle | / | 0.473 | |
| 3chw | ATP | Major actin | / | 0.470 | |
| 4h0y | LAR | Actin, alpha skeletal muscle | / | 0.467 | |
| 3qw4 | U5P | Orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | / | 0.458 | |
| 1ijj | LAR | Actin, alpha skeletal muscle | / | 0.455 | |
| 4fzv | SAM | 5-methylcytosine rRNA methyltransferase NSUN4 | 2.1.1 | 0.455 | |
| 1nmd | ATP | Major actin | / | 0.453 | |
| 4m63 | ATP | Actin-5C | / | 0.451 | |
| 2v51 | LAB | Actin, alpha skeletal muscle | / | 0.449 | |
| 2v51 | ATP | Actin, alpha skeletal muscle | / | 0.445 | |
| 3e8n | VRA | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.444 | |
| 1rfq | LAR | Actin, alpha skeletal muscle | / | 0.443 | |
| 4b1v | LAB | Actin, alpha skeletal muscle | / | 0.440 |